Alerts will be sent to your verified email
Verify Email
GODAVARI
|
Godavari Drugs
|
Vista Pharma
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.06 % | -9.01 % | 4.39 % |
|
5yr average Equity Multiplier
|
3.51 | 1.42 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
1.24 | 0.08 | 0.95 |
|
5yr Avg Net Profit Margin
|
3.28 % | -205.63 % | 2.38 % |
|
Price to Book
|
1.17 | 1.21 | 2.53 |
|
P/E
|
14.29 | 0.0 | 18.89 |
|
5yr Avg Cash Conversion Cycle
|
107.21 Days | 124.89 Days | 75.63 Days |
|
Inventory Days
|
47.15 Days | 3040.44 Days | 28.27 Days |
|
Days Receivable
|
163.82 Days | 137.33 Days | 389.8 Days |
|
Days Payable
|
106.32 Days | 1845.08 Days | 203.89 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | -2.88 | 23.53 |
|
5yr Avg ROCE
|
20.07 % | -8.17 % | 6.37 % |
|
5yr Avg Operating Profit Margin
|
8.03 % | -192.46 % | 3.78 % |
|
5 yr average Debt to Equity
|
1.34 | 0.26 | 0.03 |
|
5yr CAGR Net Profit
|
1.18 % | 19.73 % | -14.7 % |
|
5yr Average Return on Assets
|
4.0 % | -6.49 % | 2.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.61 % | 21.19 % | 46.79 % |
|
Share Pledged by Promoters
|
0.22 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.31 % | -14.25 % | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.02 % | 0.0 |
|
Godavari Drugs
|
Vista Pharma
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|